tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Francois Brisebois, 129 are a BUY (92.81%), 10 are a HOLD (7.19%).
Analyst Francois Brisebois, currently employed at LIFESCI, carries an average stock price target met ratio of 46.8% that have a potential upside of 41.58% achieved within 246 days. Previously, Francois Brisebois worked at OPPENHEIMER.
Francois Brisebois’s has documented 265 price targets and ratings displayed on 35 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PRAX, Praxis Precision Medicines at 15-Dec-2025.
Analyst best performing recommendations are on DMTK (DERMTECH).
The best stock recommendation documented was for DMTK (DERMTECH) at 1/22/2021. The price target of $53 was fulfilled within 14 days with a profit of $10.08 (23.49%) receiving and performance score of 16.78.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 06-Feb-2024
$20
$-1.52 (-7.06%)
$20
2 months 9 days ago
(28-Oct-2025)
5/6 (83.33%)
$1.41 (7.58%)
266
Buy
Since 18-Jul-2025
$20
$-1.52 (-7.06%)
$36
2 months 14 days ago
(23-Oct-2025)
2/3 (66.67%)
$1.44 (7.76%)
71
Buy
Since 21-Jul-2020
$19
2 months 15 days ago
(22-Oct-2025)
34/34 (100%)
$9.61 (102.34%)
365
Buy
Since 30-Jun-2020
$21
$-0.52 (-2.42%)
$21
10 months 2 days ago
(04-Mar-2025)
8/14 (57.14%)
$13.36 (174.87%)
472
Buy
Since 12-Aug-2019
$22
$0.48 (2.23%)
$30
11 months 27 days ago
(10-Jan-2025)
11/15 (73.33%)
$14.1 (178.48%)
713
Which stock is Francois Brisebois is most bullish on?
Which stock is Francois Brisebois is most reserved on?
What Year was the first public recommendation made by Francois Brisebois?
